The impact of COVID-19 on rheumatic musculoskeletal diseases

Funding for projects exploring the clinical course of COVID-19, diagnostic and therapeutic challenges and pathogenic mechanisms in patients with rheumatic musculoskeletal diseases.

Amount
Up to €300,000
Eligibility (if available)

Oganisations from countries that are members of the European League Against Rheumatism. Organisations from elsewhere can participate as partners but are not eligible to receive funding

Foreign participation? (where known)
Yes
Keywords
Country
Date application deadline